Skip to main content

Table 1 Demographic characteristics of study participants

From: First dengue virus seroprevalence study on Madeira Island after the 2012 outbreak indicates unreported dengue circulation

Participants

DENV seropositivea

n (%)

DENV seronegative

n (%)

Total

n (%)

Total number

28 (7.8)

330 (92.2)

358 (100)

 Male

11 (8.1)

125 (91.9)

136 (38.0)

 Female

17 (7.7)

205 (92.3)

222 (62.0)

Median age (years)

57.5

49

49

 10–19

0 (0)

19 (100)

19 (5.3)

 20–29

3 (7.9)

35 (92.1)

38 (10.6)

 30–39

3 (4.8)

59 (95.2)

62 (17.3)

 40–49

6 (9.8)

55 (90.2)

61 (17.0)

 50–59

3 (4.2)

68 (95.8)

71 (19.9)

 60+

13 (12.1)

94 (87.9)

107 (29.9)

Travel historyb

9 (7.9)

105 (92.1)

114 (31.8)

No travel historyb

19 (7.8)

225 (92.2)

244 (68.2)

YFV vaccination

3 (9.7)

28 (90.3)

31 (8.7)

No YFV vaccination

25 (7.6)

302 (92.4)

327 (91.3)

Funchal

20 (8.7)

209 (91.3)

229 (64.0)

Câmara de Lobos

1 (4.5)

21 (95.5)

22 (6.1)

Santa Cruz

3 (6.1)

46 (93.9)

49 (13.7)

Sao Vicente

1 (16.7)

5 (83.3)

6 (1.7)

Porto Moniz

1 (50)

1 (50)

2 (0.6)

Machico

0 (0)

8 (100)

8 (2.2)

Ribeira Brava

0 (0)

8 (100)

8 (2.2)

Calheta

0 (0)

6 (100)

6 (1.7)

Santana

0 (0)

4 (100)

4 (1.1)

Ponta do Sol

0 (0)

4 (100)

4 (1.1)

Porto Santo

0 (0)

2 (100)

2 (0.6)

Missing data

2 (11.1)

16 (88.8)

18 (5.0)

  1. aDengue seropositive patient identified by at least one ELISA assay and confirmed with seroneutralization assay (FRNT)
  2. bTo dengue endemic countries
  3. Abbreviations: DENV, dengue virus; YFV, yellow fever virus